Heart rhythm · 2025
Empirical cryoballoon-based left atrial appendage isolation followed by closure, including cases with LAA thrombosis, in patients with persistent atrial fibrillation and durable pulmonary vein isolation: Feasibility and long-term outcomes (CB LAAI + LAAC after durable PVI in persistent AF).
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Efe Tolga Han, Ebrahimi Ramin, Schaack David, Urbanek Lukas, Bordignon Stefano, Schmidt Boris, Chun Julian K R, Chen Shaojie
Аннотация
BACKGROUND: Left atrial appendage isolation (LAAI) may improve rhythm outcomes in atrial fibrillation (AF) but raises concerns regarding safety and thromboembolic risk.
OBJECTIVE: We evaluated the feasibility, safety, and long-term outcomes of cryoballoon (CB)-based-LAAI followed by left atrial appendage closure (LAAC).
METHODS: In this observational cohort, 101 patients with recurrent persistent AF after durable pulmonary vein isolation underwent empirical CB-based LAAI. At 6 weeks, electrical reconnection was assessed, with repeat LAAI performed if indicated. Patients were subsequently scheduled for LAAC. Procedural characteristics, complications, and long-term outcomes, including arrhythmia recurrence and major adverse cardiac events, were assessed over 3 years.
RESULTS: The median age was 69 years, 62% were male, and all had recurrent persistent AF. Durable LAAI was achieved in 81.2%; 19 patients underwent successful repeat isolation. LAAC was performed in 89 patients, with 100% implantation success. Periprocedural complications were infrequent: transient phrenic nerve palsy (2%), pericardial effusion (1%), groin hematoma (1%), and femoral pseudoaneurysm (1%). Distal LAA thrombus was detected in 10% but all underwent successful LAAC without embolic events. No periprocedural stroke, systemic embolism, or death occurred. At 3 years, freedom from atrial tachyarrhythmia was 73% at 1 year, 57% at 2 years, and 44% at 3 years. Major adverse cardiac events included ischemic stroke/transient ischemic attack (2%), major bleeding (2%), minor bleeding (2%), and all-cause mortality (3%). No device-related thrombus was observed.
CONCLUSION: Empirical CB LAAI followed by LAAC seems to be a feasible, safe, and effective strategy for patients with recurrent persistent AF after durable pulmonary vein isolation in an experienced center, offering a long-term therapeutic option for those at elevated thromboembolic and moderate bleeding risk.
OBJECTIVE: We evaluated the feasibility, safety, and long-term outcomes of cryoballoon (CB)-based-LAAI followed by left atrial appendage closure (LAAC).
METHODS: In this observational cohort, 101 patients with recurrent persistent AF after durable pulmonary vein isolation underwent empirical CB-based LAAI. At 6 weeks, electrical reconnection was assessed, with repeat LAAI performed if indicated. Patients were subsequently scheduled for LAAC. Procedural characteristics, complications, and long-term outcomes, including arrhythmia recurrence and major adverse cardiac events, were assessed over 3 years.
RESULTS: The median age was 69 years, 62% were male, and all had recurrent persistent AF. Durable LAAI was achieved in 81.2%; 19 patients underwent successful repeat isolation. LAAC was performed in 89 patients, with 100% implantation success. Periprocedural complications were infrequent: transient phrenic nerve palsy (2%), pericardial effusion (1%), groin hematoma (1%), and femoral pseudoaneurysm (1%). Distal LAA thrombus was detected in 10% but all underwent successful LAAC without embolic events. No periprocedural stroke, systemic embolism, or death occurred. At 3 years, freedom from atrial tachyarrhythmia was 73% at 1 year, 57% at 2 years, and 44% at 3 years. Major adverse cardiac events included ischemic stroke/transient ischemic attack (2%), major bleeding (2%), minor bleeding (2%), and all-cause mortality (3%). No device-related thrombus was observed.
CONCLUSION: Empirical CB LAAI followed by LAAC seems to be a feasible, safe, and effective strategy for patients with recurrent persistent AF after durable pulmonary vein isolation in an experienced center, offering a long-term therapeutic option for those at elevated thromboembolic and moderate bleeding risk.